Cargando…
Recent Advances in Combined Modality Therapy
Combined modality therapy emerged from preclinical data showing that carefully chosen drugs could enhance the sensitivity of tumor cells to radiation while having nonoverlapping toxicities. Recent advances in molecular biology involving the identification of cellular receptors, enzymes, and pathways...
Autores principales: | Mierzwa, Michelle L., Nyati, Mukesh K., Morgan, Meredith A., Lawrence, Theodore S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227964/ https://www.ncbi.nlm.nih.gov/pubmed/20413642 http://dx.doi.org/10.1634/theoncologist.2009-S105 |
Ejemplares similares
-
Targeting the TGF-β1 Pathway to Prevent Normal Tissue Injury After Cancer Therapy
por: Anscher, Mitchell S.
Publicado: (2010) -
The Road Not Taken and Choices in Radiation Oncology
por: Coleman, C. Norman, et al.
Publicado: (2010) -
About Eli
por: Chabner, Bruce A.
Publicado: (2010) -
Clinical Medicine and Clinical Trials
por: Tepper, Joel E.
Publicado: (2010) -
Imaging in Radiation Oncology: A Perspective
por: Dawson, Laura A., et al.
Publicado: (2010)